Good, bad news for Chemical Financing (Y&P article in ICIS Chemical Business) Nov 2 – Nov 8, 2018 issue
Young & Partners’ provides its analysis of what is happening in the stock market and financing worlds.
Business Check – Industry Financial Pulse (Young & Partners article in Pharm Exec Nov 2018)
An in depth look at strategic, M&A and financial trends for Pharma and Biotech
Chemical M&A – Reality vs Myth (Y&P article in ICIS Chemical Business) Oct 26 – Nov 1, 2018 issue
Young & Partners looks at the big picture trends, how they differ from conventional views, and their implications for management.
The Rise of China Biopharma (Pharmaceutical Executive – July issue)
Young & Partners analyzes the rise in China's biopharma industry, both positive and negative
Dr. Spielberg, former Deputy Commissioner of the FDA, joins Young & Partners (June 11, 2018)
Young & Partners adds to its deep regulatory and biopharma expertise
Banker: Value of Closed M&A Soars in 2017 due to Mega Deals (Feb 12 – 19, 2018, Chemical Week)
Peter Young of Young & Partners interviewed about the nuances of the Chemical M&A market in 2017
Stock Market and Financing – Strong with a Twist (ICIS Chemical Business, Feb 2, 2018 issue)
2017 was great for chemical stock market performance and financing, but not for everyone
Pharma and Biotech: Strategic, M&A and Financial Yearend Review and Outlook (Pharma Exec Feb 2018 issue)
Young & Partners reviews what happened in 2017, the future outlook and the implications for management
Chemical M&A – Below the Surface (ICIS Chemical Business, Jan 26, 2018 issue)
Young & Partners looks at the big picture trends and the nuances underneath
Chemical M&A and IPOs – A Warped View – Young & Partners (ICIS Chemical Business Nov. 10 – 16, 2017 issue)
Amid talk of a hot M&A market and IPOs, if you take a hard look at the numbers, reality is different